TNONW

NASD Tenon Medical, Inc. - Warrant
Oct 2, 2026 · 1:40 PM ET DELAYED Market Open

$0.0073 ↑ +0.0007 (+10.61%) Trading Up from the previous close of $0.0066, and at the day’s high of $0.0082

YTD change
-30.48%
vs 20-day SMA
+12.74%
vs 200-day SMA
-37.94%

Price ranges

Previous day
$0.0063 $0.0075
open $0.0069 close $0.0066
-$0.0003 (-4.35%)
Today
$0.0054 $0.0082
open $0.0072 now $0.0073
+$0.0001 (+1.39%)
Past week
$0.0050 $0.0099
from $0.0056 now $0.0073
+$0.0017 (+30.36%)
Past month
$0.0050 $0.0169
from $0.0089 now $0.0073
-$0.0016 (-17.98%)
This year
$0.0042 $0.0430
from $0.0105 now $0.0073
-$0.0032 (-30.48%)

Price & Performance

-0.00 (-17.50%) / 6M

$0.0039$0.0104$0.0168$0.0233Apr 6Jul 15Oct 1

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 87.3% away from all-time highs of $0.0575
  • TNONW is down 30% since the beginning of the year
  • TNONW is down 59% over the past 12 months
  • TNONW is down 18% over the past 1 month

TNONW reads not so good: price sits above one of the two key moving averages, the 12-month move is -63.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A
EPS N/A
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A

Balance sheet & scale

IncomeN/A
RevenueN/A
CashN/A
DebtN/A
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap N/A

Competitor comparison

TickerCompany PriceChange
SYK Stryker Corporation $272.96 -0.88%
STE STERIS plc $209.34 -0.32%
SNN Smith & Nephew plc Sponsored ADR $26.58 -1.41%
WILYY Demant A/S Unsponsored ADR $24.50 +5.88%
GKOS Glaukos Corp $163.17 -0.62%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.